Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... period from 2025 to 2032. The market is witnessing rapid growth due to increasing healthcare demands, the expiration of biologic drug patents, and the cost-efficiency of biosimilars compared to branded biologics. The expanding burden of ... Read More
-
Peptide Therapeutics Market Size, Share, Trends, Industry Analysis, and Forecast (2025 – 2031)
... period. Peptide Therapeutics Market Overview Peptide therapeutics represents a significant advancement in the pharmaceutical industry, leveraging short chains of amino acids that play crucial roles in various biological processes. These therapeutic agents are designed to ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $329,798,300,375 by 2031. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Global Biosimilars of Factor X agonists Industry Growth and Trends Forecast to 2031
... CAGR of xx% during the forecast period 2026-2031. North American market for Biosimilars of Factor X agonists is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR ... Read More
-
Global Biosimilars of Factor X agonists Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... % during the forecast period. The US & Canada market for Biosimilars of Factor X agonists is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of ... Read More
-
Global Perfusion Bioreactors Market Growth 2025-2031
... 2031. Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor. Perfusion bioreactors ... Read More
-
Global Biosimilars of Factor X agonists Market Outlook and Growth Opportunities 2025
... % during the forecast period. The North American market for Biosimilars of Factor X agonists is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % ... Read More
-
Human Immunoglobulin
... CAGR of 8.9% over the analysis period 2024-2030. Autoimmune Disorders Application, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$12.6 Billion by the end of the ... Read More
-
Global Wound Care Biologics Market Growth (Status and Outlook) 2025-2031
... to 2031. Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics ... Read More
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and scale faster, contract development and manufacturing organizations (CDMOs) are emerging as indispensable partners. Market Insights The biologics contract manufacturing market is projected to grow significantly, from a valuation of USD 21.9 billion in 2025 ... Read More
-
The 2026-2031 World Outlook for Biosimilar Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Biopharmaceutical Third Party Logistics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Biopharmaceutical Logistics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Biologics Development and Manufacturing Testing
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Biopharmaceutical Bioseparation Chromatography
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Generic Biosimilars
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Membrane Bioreactors
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Biosimilars
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Biosimilars and Follow-on Biologics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Anti-Inflammatory Biologics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Aseptic Sampling
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Erythropoietin Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Erythropoietins
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Erythropoietin Stimulating Agents
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
Research Assistance
